Please enable JavaScript
Powered by Benchmark Saransh Kanaujia, Author at Matribhumi Samachar English - Page 321 of 2911
Monday, March 30 2026 | 07:03:16 AM
Home / Saransh Kanaujia (page 321)

Saransh Kanaujia

Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.

Lux Metals Upsizes Private Placement to $4,000,000

Vancouver, British Columbia–(Newsfile Corp. – January 16, 2026) – Lux Metals Corp. (TSXV: LXM) (the “Company” or “Lux“) announces that further to its news releases dated December 10, 2025 and December 23, 2025, it has increased the size of its previously announced private placement from up to 17,500,000 units of …

Read More »

CDN Maverick Announces Normal Course Issuer Bid

Vancouver, British Columbia–(Newsfile Corp. – January 16, 2026) – CDN Maverick Capital Corp. (CSE: CDN) (OTCQB: AXVEF) (FSE: 338B) (“Maverick” or the “Company”) announces the implementation of a normal course issuer bid (“NCIB”) to purchase up to 1,048,061 of its common shares (the “Shares”) representing approximately 5% of the Company’s …

Read More »

Talent Infinity Announces Appointment of New Director

Vancouver, British Columbia–(Newsfile Corp. – January 16, 2026) – Talent Infinity Resource Developments Inc. (CSE:TICO) (“Talent” or the “Company“) announces the appointment of Mr. Chris Beltgens as director of the Company. Mr. Beltgens has over 15 years of investment, business development and corporate finance experience and he currently serves as …

Read More »

Renegade Gold Announces Grant of Stock Options

Vancouver, British Columbia–(Newsfile Corp. – January 16, 2026) – Renegade Gold Inc. (TSXV: RAGE) (OTCQB: TGLDF) (FSE: 0700) (“Renegade” or the “Company“) announces that a total of 3,025,000 incentive stock options have been granted to directors, officers, and consultants of the Company pursuant to the Company’s Long Term Incentive Plan. …

Read More »

Badlands Provides Update Respecting Private Placement

Vancouver, British Columbia–(Newsfile Corp. – January 16, 2026) – Badlands Resources Inc. (TSXV: BLDS) (FSE: B7Q) (“Badlands” or the “Company“) announces that, further to its October 23, 2025 and December 8, 2025 news releases, it is still pursuing its previously announced non-brokered private placement of up to 14,666,667 units (“Units“) …

Read More »

Bonterra Announces Results of Canada Revenue Agency Audit

Val-d’Or, Quebec–(Newsfile Corp. – January 16, 2026) – Bonterra Resources Inc. (TSXV: BTR) (OTCQX: BONXF) (FSE: 9BR2) (“Bonterra” or the “Company“) announces that the Canada Revenue Agency (“CRA“) is completing a tax audit (the “Audit“) of the Company’s renunciation of Canadian exploration expenses (“CEE“) in favour of subscribers of the …

Read More »

The FUTR Corporation Appoints Technology Financier G. Scott Paterson to its Board of Directors and as Chairman of the Board

Successful Serial Entrepreneur, Former Vice Chairman of the Toronto Stock Exchange Steps Forward in Expanded Role. Toronto, Ontario–(Newsfile Corp. – January 16, 2026) – The FUTR Corporation (TSXV: FTRC) (OTCQB: FTRCF) (FSE: QA20) (WKN: A4165Y) (ISIN: CA3609521057) (“FUTR” or the “Company”), creator of the FUTR Agent App which enables users …

Read More »

Vertiqal Studios Announces Sale of Luminosity Gaming

Toronto, Ontario–(Newsfile Corp. – January 16, 2026) – Vertiqal Studios Corp. (TSX: VRTS) (FSE: 9PY0) (“Vertiqal” or the “Company”) Vertiqal, a leading digital-channel network and video-production studio, as well as the owner of North America’s largest gaming and lifestyle network on social media, today announces that it has completed the …

Read More »

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario–(Newsfile Corp. – January 16, 2026) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company“), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and global commercial activities. 2025 …

Read More »